Pharmaceutical Excipient Market Research Report by Function (Binders, Coating Agents, Colorants, Disintegrants, and Emulsifying Agents), by Type (Inorganic and Organic), by Formulation - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pharmaceutical Excipient Market is expected to grow from USD 7,159.54 Million in 2020 to USD 9,453.23 Million by the end of 2025.
2. The Global Pharmaceutical Excipient Market is expected to grow from EUR 6,277.62 Million in 2020 to EUR 8,288.77 Million by the end of 2025.
3. The Global Pharmaceutical Excipient Market is expected to grow from GBP 5,580.82 Million in 2020 to GBP 7,368.74 Million by the end of 2025.
4. The Global Pharmaceutical Excipient Market is expected to grow from JPY 764,104.55 Million in 2020 to JPY 1,008,899.74 Million by the end of 2025.
5. The Global Pharmaceutical Excipient Market is expected to grow from AUD 10,396.60 Million in 2020 to AUD 13,727.35 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Excipient to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the Pharmaceutical Excipient Market studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
Based on Type, the Pharmaceutical Excipient Market studied across Inorganic and Organic. The Inorganic further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins.
Based on Formulation, the Pharmaceutical Excipient Market studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations further studied across Capsules, Liquid Formulations, and Tablets.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pharmaceutical Excipient Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded the largest size in the Pharmaceutical Excipient Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Excipient Market including Air Liquide S.A., Archer Daniels Midland Company, Ashland Global Holdings Inc., Associated British Foods PLC, BASF SE, Budenheim, Captisol, Colorcon Inc., Croda International, Daicel, DMV-Fonterra Excipients GmbH & Co. KG, Dupont De Nemours, Inc., Evonik Industries AG, Fuji Chemical, GalenIQ, Gattefoss?, Innophos Holdings Inc., JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Lubrizol Life Science Health, Roquette Fr?res, and WACKER Chemie AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Excipient Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Excipient Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Excipient Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Excipient Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Excipient Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Excipient Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pharmaceutical Excipient Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pharmaceutical Excipient Market is expected to grow from USD 7,159.54 Million in 2020 to USD 9,453.23 Million by the end of 2025.
2. The Global Pharmaceutical Excipient Market is expected to grow from EUR 6,277.62 Million in 2020 to EUR 8,288.77 Million by the end of 2025.
3. The Global Pharmaceutical Excipient Market is expected to grow from GBP 5,580.82 Million in 2020 to GBP 7,368.74 Million by the end of 2025.
4. The Global Pharmaceutical Excipient Market is expected to grow from JPY 764,104.55 Million in 2020 to JPY 1,008,899.74 Million by the end of 2025.
5. The Global Pharmaceutical Excipient Market is expected to grow from AUD 10,396.60 Million in 2020 to AUD 13,727.35 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Excipient to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the Pharmaceutical Excipient Market studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
Based on Type, the Pharmaceutical Excipient Market studied across Inorganic and Organic. The Inorganic further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins.
Based on Formulation, the Pharmaceutical Excipient Market studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations further studied across Capsules, Liquid Formulations, and Tablets.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pharmaceutical Excipient Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded the largest size in the Pharmaceutical Excipient Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Excipient Market including Air Liquide S.A., Archer Daniels Midland Company, Ashland Global Holdings Inc., Associated British Foods PLC, BASF SE, Budenheim, Captisol, Colorcon Inc., Croda International, Daicel, DMV-Fonterra Excipients GmbH & Co. KG, Dupont De Nemours, Inc., Evonik Industries AG, Fuji Chemical, GalenIQ, Gattefoss?, Innophos Holdings Inc., JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Lubrizol Life Science Health, Roquette Fr?res, and WACKER Chemie AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Excipient Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Excipient Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Excipient Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Excipient Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Excipient Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Excipient Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pharmaceutical Excipient Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Function Outlook
3.4. Type Outlook
3.5. Formulation Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth of the pharmaceuticals market supported by functional excipients
5.1.1.2. Surge in the generics market & rising adoption of orphan drugs
5.1.2. Restraints
5.1.2.1. Increasing regulatory stringency
5.1.3. Opportunities
5.1.3.1. Shifting focus of pharmaceutical manufacturing to developing countries
5.1.3.2. Multifunctional excipient
5.1.4. Challenges
5.1.4.1. Changing trade policies between countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY FUNCTION
6.1. Introduction
6.2. Binders
6.3. Coating Agents
6.4. Colorants
6.5. Disintegrants
6.6. Emulsifying Agents
6.7. Fillers & Diluents
6.8. Flavoring Agents & Sweeteners
6.9. Lubricants & Glidants
6.10. Preservatives
6.11. Suspending & Viscosity Agents
7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY TYPE
7.1. Introduction
7.2. Inorganic
7.2.1. Calcium Carbonate
7.2.2. Calcium Phosphate
7.2.3. Calcium Sulfate
7.2.4. Halites
7.2.5. Metal Oxides
7.3. Organic
7.3.1. Carbohydrates
7.3.1.1. Cellulose
7.3.1.2. Starch
7.3.1.3. Sugars
7.3.2. Oleochemicals
7.3.2.1. Fatty Alcohols
7.3.2.2. Glycerin
7.3.2.3. Mineral Stearates
7.3.3. Petrochemicals
7.3.3.1. Acrylic Polymers
7.3.3.2. Glycols
7.3.3.3. Mineral Hydrocarbons
7.3.3.4. Povidones
7.3.4. Proteins
8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY FORMULATION
8.1. Introduction
8.2. Oral Formulations
8.2.1. Capsules
8.2.1.1. Hard Gelatin Capsules
8.2.1.2. Soft Gelatin Capsules
8.2.2. Liquid Formulations
8.2.3. Tablets
8.3. Parenteral Formulations
8.4. Topical Formulations
9. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Air Liquide S.A.
13.2. Archer Daniels Midland Company
13.3. Ashland Global Holdings Inc.
13.4. Associated British Foods PLC
13.5. BASF SE
13.6. Budenheim
13.7. Captisol
13.8. Colorcon Inc.
13.9. Croda International
13.10. Daicel
13.11. DMV-Fonterra Excipients GmbH & Co. KG
13.12. Dupont De Nemours, Inc.
13.13. Evonik Industries AG
13.14. Fuji Chemical
13.15. GalenIQ
13.16. Gattefoss?
13.17. Innophos Holdings Inc.
13.18. JRS Pharma GmbH & Co. KG
13.19. Kerry Group PLC
13.20. Lubrizol Corporation
13.21. Lubrizol Life Science Health
13.22. Roquette Fr?res
13.23. WACKER Chemie AG
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Function Outlook
3.4. Type Outlook
3.5. Formulation Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth of the pharmaceuticals market supported by functional excipients
5.1.1.2. Surge in the generics market & rising adoption of orphan drugs
5.1.2. Restraints
5.1.2.1. Increasing regulatory stringency
5.1.3. Opportunities
5.1.3.1. Shifting focus of pharmaceutical manufacturing to developing countries
5.1.3.2. Multifunctional excipient
5.1.4. Challenges
5.1.4.1. Changing trade policies between countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY FUNCTION
6.1. Introduction
6.2. Binders
6.3. Coating Agents
6.4. Colorants
6.5. Disintegrants
6.6. Emulsifying Agents
6.7. Fillers & Diluents
6.8. Flavoring Agents & Sweeteners
6.9. Lubricants & Glidants
6.10. Preservatives
6.11. Suspending & Viscosity Agents
7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY TYPE
7.1. Introduction
7.2. Inorganic
7.2.1. Calcium Carbonate
7.2.2. Calcium Phosphate
7.2.3. Calcium Sulfate
7.2.4. Halites
7.2.5. Metal Oxides
7.3. Organic
7.3.1. Carbohydrates
7.3.1.1. Cellulose
7.3.1.2. Starch
7.3.1.3. Sugars
7.3.2. Oleochemicals
7.3.2.1. Fatty Alcohols
7.3.2.2. Glycerin
7.3.2.3. Mineral Stearates
7.3.3. Petrochemicals
7.3.3.1. Acrylic Polymers
7.3.3.2. Glycols
7.3.3.3. Mineral Hydrocarbons
7.3.3.4. Povidones
7.3.4. Proteins
8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY FORMULATION
8.1. Introduction
8.2. Oral Formulations
8.2.1. Capsules
8.2.1.1. Hard Gelatin Capsules
8.2.1.2. Soft Gelatin Capsules
8.2.2. Liquid Formulations
8.2.3. Tablets
8.3. Parenteral Formulations
8.4. Topical Formulations
9. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Air Liquide S.A.
13.2. Archer Daniels Midland Company
13.3. Ashland Global Holdings Inc.
13.4. Associated British Foods PLC
13.5. BASF SE
13.6. Budenheim
13.7. Captisol
13.8. Colorcon Inc.
13.9. Croda International
13.10. Daicel
13.11. DMV-Fonterra Excipients GmbH & Co. KG
13.12. Dupont De Nemours, Inc.
13.13. Evonik Industries AG
13.14. Fuji Chemical
13.15. GalenIQ
13.16. Gattefoss?
13.17. Innophos Holdings Inc.
13.18. JRS Pharma GmbH & Co. KG
13.19. Kerry Group PLC
13.20. Lubrizol Corporation
13.21. Lubrizol Life Science Health
13.22. Roquette Fr?res
13.23. WACKER Chemie AG
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: SCORES
TABLE 134. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: BUSINESS STRATEGY
TABLE 135. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: PRODUCT SATISFACTION
TABLE 136. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: RANKING
TABLE 137. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: MERGER & ACQUISITION
TABLE 138. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 139. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 140. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: INVESTMENT & FUNDING
TABLE 141. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 142. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: SCORES
TABLE 134. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: BUSINESS STRATEGY
TABLE 135. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: PRODUCT SATISFACTION
TABLE 136. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: RANKING
TABLE 137. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: MERGER & ACQUISITION
TABLE 138. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 139. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 140. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: INVESTMENT & FUNDING
TABLE 141. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 142. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2020 VS 2025 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025
FIGURE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025
FIGURE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2020 VS 2025 (%)
FIGURE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025
FIGURE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2020 VS 2025 (USD MILLION)
FIGURE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, 2020 VS 2025 (USD MILLION)
FIGURE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, 2020 VS 2025 (USD MILLION)
FIGURE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, 2020 VS 2025 (USD MILLION)
FIGURE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 62. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 63. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 65. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 71. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 72. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 73. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 83. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 84. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 85. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 87. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 88. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 89. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 90. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 91. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 92. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 93. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 94. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 95. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 96. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 97. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 98. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 99. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY TYPE
FIGURE 1. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2020 VS 2025 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025
FIGURE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025
FIGURE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2020 VS 2025 (%)
FIGURE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025
FIGURE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CAPSULES, 2020 VS 2025 (USD MILLION)
FIGURE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, 2020 VS 2025 (USD MILLION)
FIGURE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, 2020 VS 2025 (USD MILLION)
FIGURE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, 2020 VS 2025 (USD MILLION)
FIGURE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 62. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 63. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 65. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 71. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 72. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 73. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 83. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 84. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 85. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 87. ITALY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 88. NETHERLANDS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 89. QATAR PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 90. RUSSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 91. SAUDI ARABIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 92. SOUTH AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 93. SPAIN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 94. UNITED ARAB EMIRATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 95. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 96. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 97. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 98. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 99. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, BY TYPE
